22 related articles for article (PubMed ID: 8925518)
1. Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer.
Schantz SP; Brown BW; Lira E; Taylor DL; Beddingfield N
Cancer Immunol Immunother; 1987; 25(2):141-8. PubMed ID: 3499224
[TBL] [Abstract][Full Text] [Related]
2. Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy.
Ichim CV
J Transl Med; 2005 Feb; 3(1):8. PubMed ID: 15698481
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
[TBL] [Abstract][Full Text] [Related]
4. Head and neck cancer triggers the internalization of TLR3 in natural killer cells.
Xie L; Pries R; Kesselring R; Wulff S; Wollenberg B
Int J Mol Med; 2007 Oct; 20(4):493-9. PubMed ID: 17786279
[TBL] [Abstract][Full Text] [Related]
5. Influence of serum derived from patients with head and neck cancer on natural killer cell activity.
Kumazawa H; Hess M
Oncology; 1991; 48(5):372-6. PubMed ID: 1745484
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of NK cell function against head and neck cancer in response to ss-isRNA requires TLR7.
Pries R; Wulff S; Kesselring R; Börngen K; Xie L; Wollenberg B
Int J Oncol; 2008 Nov; 33(5):993-1000. PubMed ID: 18949362
[TBL] [Abstract][Full Text] [Related]
7. Expansion of natural killer cells in patients with head and neck cancer: detection of "noninhibitory" (activating) killer Ig-like receptors on circulating natural killer cells.
Melioli G; Semino C; Margarino G; Mereu P; Scala M; Cangemi G; Crocetti E; Machì AM; Ferlazzo G
Head Neck; 2003 Apr; 25(4):297-305. PubMed ID: 12658734
[TBL] [Abstract][Full Text] [Related]
8. Human natural killer cells: a comprehensive review.
Sinkovics JG; Horvath JC
Int J Oncol; 2005 Jul; 27(1):5-47. PubMed ID: 15942642
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cells preferentially target cancer stem cells; role of monocytes in protection against NK cell mediated lysis of cancer stem cells.
Jewett A; Tseng HC; Arasteh A; Saadat S; Christensen RE; Cacalano NA
Curr Drug Deliv; 2012 Jan; 9(1):5-16. PubMed ID: 22023212
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory serum components in head and neck cancer.
Yamanaka N
Eur J Cancer B Oral Oncol; 1993 Apr; 29B(2):103-6. PubMed ID: 8180585
[No Abstract] [Full Text] [Related]
11. Suppression of natural killer cell activity by serum derived from head and neck cancer patients.
Kumazawa H; Minamino M; Yukawa N; Hess M
Cancer Detect Prev; 1995; 19(6):494-502. PubMed ID: 8925518
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
